Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INDT
2726
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $855K | ﹤0.01% |
23,300
+4,500
| +24% | +$165K |
|
2727
Stryker
SYK
$133B
| $852K | ﹤0.01% |
5,500
-79,300
| -94% | -$12.1M |
|
2728
Compugen
CGEN
$228M
| $850K | ﹤0.01% |
340,008
+71,308
| +27% | +$212K |
|
2729
MIND Technology
MIND
$42.4M
| $846K | ﹤0.01% |
26,702
+1,842
| +7% | +$66K |
|
2730
Worthington Enterprises
WOR
$2.78B
| $843K | ﹤0.01% |
31,016
-613
| -2% | -$16.4K |
|
2731
Oramed Pharmaceuticals
ORMP
$178M
| $842K | ﹤0.01% |
93,500
+10,500
| +13% | +$100K |
|
|
ZIV
2732
DELISTED
VelocityShares Daily Inverse VIX Medium Term ETN
ZIV
| $842K | ﹤0.01% |
+9,500
| New | +$767K |
|
2733
Orion Energy Systems
OESX
$84.2M
| $841K | ﹤0.01% |
95,567
+11,297
| +13% | +$104K |
|
|
XNET
2734
Xunlei
XNET
$316M
| $833K | ﹤0.01% |
54,100
-91,500
| -63% | -$1.05M |
|
2735
Fuel Tech
FTEK
$45.9M
| $828K | ﹤0.01% |
739,000
+97,500
| +15% | +$98.5K |
|
2736
SELLAS Life Sciences
SLS
$2.5B
| $828K | ﹤0.01% |
2,107
+260
| +14% | +$126K |
|
2737
ImmuCell
ICCC
$99.3M
| $825K | ﹤0.01% |
93,900
-4,300
| -4% | -$35.2K |
|
|
CFMS
2738
DELISTED
Conformis, Inc. Common Stock
CFMS
| $825K | ﹤0.01% |
13,872
+11,964
| +627% | +$956K |
|
|
BSJI
2739
DELISTED
Invesco BulletShares 2018 High Yield Corporate Bond ETF
BSJI
| $823K | ﹤0.01% |
+32,787
| New | +$826K |
|
2740
DXP Enterprises
DXPE
$3.04B
| $816K | ﹤0.01% |
27,600
-55,700
| -67% | -$1.62M |
|
|
PVG
2741
DELISTED
PRETIUM RESOURCES INC.
PVG
| $812K | ﹤0.01% |
+70,900
| New | +$772K |
|
|
FWDI
2742
Forward Industries Inc
FWDI
$305M
| $808K | ﹤0.01% |
65,670
+1,730
| +3% | +$21.7K |
|
|
OTIV
2743
DELISTED
OTI On Track Innovations Ltd
OTIV
| $805K | ﹤0.01% |
592,000
-117,481
| -17% | -$153K |
|
2744
Noodles & Co
NDLS
$98M
| $803K | ﹤0.01% |
19,125
-13,463
| -41% | -$516K |
|
2745
First Trust Europe AlphaDEX Fund
FEP
$534M
| $801K | ﹤0.01% |
+20,500
| New | +$780K |
|
2746
Hecla Mining
HL
$11.9B
| $799K | ﹤0.01% |
201,300
-1,690,300
| -89% | -$7.35M |
|
|
CCM
2747
Concord Medical Services
CCM
$20.8M
| $795K | ﹤0.01% |
23,860
+1,220
| +5% | +$44.7K |
|
2748
Ceco Environmental
CECO
$4.44B
| $793K | ﹤0.01% |
154,600
-13,700
| -8% | -$92.2K |
|
2749
Vericel Corp
VCEL
$2.29B
| $792K | ﹤0.01% |
145,400
-104,792
| -42% | -$483K |
|
|
HSNI
2750
DELISTED
HSN, Inc.
HSNI
| $791K | ﹤0.01% |
19,600
-18,100
| -48% | -$716K |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.